Scimago Journal & Country Rank
menu
| Title | Type | SJR |  H index |
Total Docs. (2010) | Total Docs. (3years) | Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2010) | %Female (2010) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99 | Advances in Pharmacological Sciences | journal | 0.105 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 |  |
| 98 | Current Clinical Pharmacology | journal | 0.732 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 |  |
| 97 | Life Science Clusters | trade journal | 0.100 Q4 | 0 | 11 | 60 | 0 | 0 | 55 | 0.00 | 0.00 | 37.50 |  |
| 96 | European Life Science Journal | trade journal | 0.100 Q4 | 1 | 35 | 86 | 3 | 1 | 85 | 0.01 | 0.09 | 10.71 |  |
| 95 | PharmacoVigilance Review | journal | 2 | 23 | 0 | 66 | 0 | 0 | 0.00 | 2.87 | 40.00 | | |
| 94 | Azerbaijan Pharmaceutical and Pharmacotherapy Journal | journal | 0.100 Q4 | 3 | 18 | 36 | 202 | 0 | 36 | 0.00 | 11.22 | 40.00 |  |
| 93 | Pharmaceutical Manufacturing and Packing Sourcer | trade journal | 0.100 Q4 | 3 | 67 | 71 | 246 | 1 | 71 | 0.01 | 3.67 | 15.85 | |
| 92 | Contract Pharma | trade journal | 0.101 Q4 | 4 | 146 | 103 | 119 | 3 | 86 | 0.03 | 0.82 | 23.08 | |
| 91 | Pharmaceutical Processing | trade journal | 0.125 Q3 | 4 | 50 | 58 | 78 | 5 | 47 | 0.09 | 1.56 | 20.83 | |
| 90 | PharmacoEconomics - German Research Articles | journal | 5 | 9 | 0 | 239 | 0 | 0 | 0.00 | 26.56 | 21.05 |  | |
| 89 | Arzneimitteltherapie | journal | 0.105 Q4 | 6 | 138 | 300 | 1195 | 11 | 123 | 0.04 | 8.66 | 40.00 |  |
| 88 | Botulinum Journal | journal | 0.114 Q4 | 6 | 8 | 8 | 292 | 3 | 6 | 0.38 | 36.50 | 21.05 |  |
| 87 | EJHP Practice | trade journal | 0.117 Q3 | 6 | 73 | 148 | 718 | 13 | 102 | 0.09 | 9.84 | 44.80 |  |
| 86 | Milestones in Drug Therapy | book series | 6 | 41 | 0 | 3385 | 0 | 0 | 0.00 | 82.56 | 29.90 | | |
| 85 | Pharmacoeconomics - Spanish Research Articles | journal | 0.151 Q3 | 6 | 15 | 45 | 458 | 14 | 40 | 0.20 | 30.53 | 20.41 | |
| 84 | Pharmacometrics | journal | 0.113 Q4 | 7 | 23 | 16 | 309 | 3 | 16 | 0.19 | 13.43 | 27.59 |  |
| 83 | Regulatory Rapporteur | trade journal | 7 | 76 | 0 | 360 | 0 | 0 | 0.00 | 4.74 | 49.45 | | |
| 82 | Alimentary Pharmacology and Therapeutics Symposium Series | journal | 0.118 Q3 | 8 | 0 | 12 | 0 | 1 | 12 | 0.00 | 0.00 | 0.00 | |
| 81 | European Pharmaceutical Journal | journal | 0.121 Q3 | 9 | 12 | 21 | 336 | 4 | 19 | 0.19 | 28.00 | 53.57 | |
| 80 | European Pharmaceutical Review | trade journal | 0.120 Q3 | 9 | 43 | 29 | 799 | 4 | 23 | 0.14 | 18.58 | 18.84 | |
| 79 | Hacettepe University Journal of the Faculty of Pharmacy | journal | 0.127 Q3 | 9 | 12 | 25 | 498 | 6 | 25 | 0.24 | 41.50 | 76.32 |  |
| 78 | Journal of Pharmaceutical Research and Health Care | journal | 10 | 48 | 0 | 767 | 0 | 0 | 0.00 | 15.98 | 32.00 |  | |
| 77 | Research Journal of Pharmacology (discontinued) | journal | 0.103 Q4 | 10 | 18 | 24 | 385 | 3 | 24 | 0.13 | 21.39 | 13.33 |  |
| 76 | Pharmaceuticals Policy and Law | journal | 0.133 Q3 | 11 | 55 | 98 | 484 | 15 | 93 | 0.11 | 8.80 | 52.05 |  |
| 75 | Quality Assurance Journal | journal | 0.109 Q4 | 11 | 11 | 47 | 73 | 11 | 39 | 0.10 | 6.64 | 25.93 | |
| 74 | Trends in Medical Research (discontinued) | journal | 0.115 Q3 | 11 | 5 | 20 | 279 | 5 | 20 | 0.25 | 55.80 | 0.00 | |
| 73 | Advances in Antiviral Drug Design | book series | 0.320 Q2 | 12 | 0 | 7 | 0 | 6 | 6 | 0.00 | 0.00 | 0.00 | |
| 72 | Archives of Drug Information | journal | 0.251 Q2 | 12 | 7 | 24 | 136 | 18 | 23 | 0.75 | 19.43 | 40.00 | |
| 71 | Chinese Journal of New Drugs | journal | 0.105 Q4 | 12 | 250 | 1020 | 3029 | 45 | 1020 | 0.04 | 12.12 | 41.08 |  |
| 70 | Pharma Times | journal | 0.103 Q4 | 12 | 89 | 230 | 602 | 18 | 163 | 0.09 | 6.76 | 24.42 | |
| 69 | Handbook of Analytical Separations | book series | 0.181 Q2 | 13 | 0 | 32 | 0 | 7 | 0 | 0.22 | 0.00 | 0.00 | |
| 68 | Methods in Pharmacology and Toxicology | book series | 0.110 Q4 | 14 | 0 | 22 | 0 | 4 | 21 | 0.18 | 0.00 | 0.00 | |
| 67 | Chiang Mai University Journal of Natural Sciences | journal | 0.101 | 15 | 26 | 24 | 650 | 0 | 24 | 0.00 | 25.00 | 70.83 |  |
| 66 | NATO Security through Science Series A: Chemistry and Biology | book series | 0.130 Q3 | 15 | 0 | 174 | 0 | 50 | 173 | 0.46 | 0.00 | 0.00 | |
| 65 | Open Access Journal of Clinical Trials | journal | 0.116 Q3 | 15 | 18 | 4 | 632 | 1 | 4 | 0.25 | 35.11 | 50.00 | |
| 64 | American Journal of Pharmacy Benefits | journal | 16 | 56 | 0 | 911 | 0 | 0 | 0.00 | 16.27 | 44.76 | | |
| 63 | Drug Target Insights | journal | 0.103 Q4 | 16 | 0 | 15 | 0 | 3 | 15 | 0.20 | 0.00 | 0.00 |  |
| 62 | Neuropsychopharmacologia Hungarica | journal | 0.175 Q2 | 18 | 27 | 78 | 791 | 28 | 68 | 0.39 | 29.30 | 43.18 |  |
| 61 | Journal of Pharmaceutical Health Services Research | journal | 19 | 29 | 0 | 763 | 0 | 0 | 0.00 | 26.31 | 50.65 | | |
| 60 | Vitae | journal | 0.155 Q3 | 19 | 27 | 40 | 730 | 8 | 38 | 0.20 | 27.04 | 43.75 |  |
| 59 | African Journal Biomedical Research | journal | 0.226 Q2 | 20 | 36 | 47 | 806 | 31 | 47 | 0.66 | 22.39 | 30.91 |  |
| 58 | Current Drug Therapy | journal | 0.171 Q2 | 20 | 37 | 77 | 2475 | 50 | 74 | 0.66 | 66.89 | 28.57 | |
| 57 | Journal of Medical Marketing | journal | 0.224 Q2 | 20 | 38 | 140 | 835 | 51 | 116 | 0.37 | 21.97 | 25.00 | |
| 56 | Journal of Research in Pharmacy | journal | 20 | 22 | 0 | 735 | 0 | 0 | 0.00 | 33.41 | 44.12 | | |
| 55 | Global Journal of Pharmacology (discontinued) | journal | 21 | 24 | 0 | 559 | 0 | 0 | 0.00 | 23.29 | 24.00 | | |
| 54 | Journal of Pharmacology and Toxicology (discontinued) | journal | 0.294 Q2 | 22 | 11 | 88 | 320 | 55 | 88 | 0.63 | 29.09 | 32.00 | |
| 53 | American Journal of Pharmacology and Toxicology (discontinued) | journal | 0.217 Q2 | 24 | 22 | 71 | 700 | 56 | 71 | 0.92 | 31.82 | 33.82 | |
| 52 | Neuromethods | book series | 0.138 Q3 | 24 | 76 | 64 | 4822 | 9 | 58 | 0.14 | 63.45 | 28.57 | |
| 51 | Journal of Negative Results in BioMedicine | journal | 0.375 Q1 | 25 | 10 | 34 | 342 | 37 | 33 | 1.04 | 34.20 | 47.17 | |
| 50 | Pharmaceutical Sciences | journal | 0.102 Q4 | 26 | 21 | 42 | 558 | 2 | 42 | 0.05 | 26.57 | 23.21 |  |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data